Page 103 - Read Online

Page 270 Franca et al. Cancer Drug Resist 2019;2:256-70 I http://dx.doi.org/10.20517/cdr.2019.004

67. de Kreuk BJ, Anthony EC, Geerts D, Hordijk PL. The F-BAR protein PACSIN2 regulates epidermal growth factor receptor
internalization. J Biol Chem 2012;287:43438-53.
68. Hansen CG, Howard G, Nichols BJ. Pacsin 2 is recruited to caveolae and functions in caveolar biogenesis. J Cell Sci 2011;124:2777-85.
69. Ritter B, Modregger J, Paulsson M, Plomann M. PACSIN 2, a novel member of the PACSIN family of cytoplasmic adapter proteins.
FEBS Lett 1999;454:356-62.
70. Stocco G, Yang W, Crews KR, Thierfelder WE, Decorti G, et al. PACSIN2 polymorphism influences TPMT activity and
mercaptopurine-related gastrointestinal toxicity. Hum Mol Genet 2012;21:4793-804.
71. Smid A, Karas-Kuzelicki N, Jazbec J, Mlinaric-Rascan I. PACSIN2 polymorphism is associated with thiopurine-induced hematological
toxicity in children with acute lymphoblastic leukaemia undergoing maintenance therapy. Sci Rep 2016;6:30244.
72. Lam BD, Hordijk PL. The Rac-1 hypervariable region in targeting and signaling: a tail of many stories. Small GTPases 2013;4:78-89.
73. Seinen ML, van Nieuw Amerongen GP, de Boer NK, Mulder CJ, van Bezu J, et al. Rac-1 as a potential pharmacodynamic biomarker
for thiopurine therapy in inflammatory bowel disease. Ther Drug Monit 2016;38:621-7.
74. Shin JY, Wey M, Umutesi HG, Sun X, Simecka J, et al. Thiopurine prodrugs mediate immunosuppressive effects by interfering with
Rac-1 protein function. J Biol Chem 2016;291:13699-714.
75. Sugihara K, Nakatsuji N, Nakamura K, Nakao K, Hashimoto R, et al. Rac-1 is required for the formation of three germ layers during
gastrulation. Oncogene 1998;17:3427-33.
76. Poppe D, Tiede I, Fritz G, Becker C, Bartsch B, et al. Azathioprine suppresses ezrin-radixin-moesin-dependent T cell-APC conjugation
through inhibition of Vav guanosine exchange activity on Rac proteins. J Immunol 2006;176:640-51.
77. Muise AM, Walters T, Xu W, Shen-Tu G, Guo CH, et al. Single nucleotide polymorphisms that increase expression of the guanosine
triphosphatase Rac-1 are associated with ulcerative colitis. Gastroenterology 2011;141:633-41.
78. Lev-Tzion R, Renbaum P, Beeri R, Ledder O, Mevorach R, et al. Rac-1 polymorphisms and thiopurine efficacy in children with
inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2015;61:404-7.
79. Koifman E, Karban A, Mazor Y, Chermesh I, Waterman M, et al. Thiopurine effectiveness in patients with Crohn’s disease: a study of
genetic and clinical predictive factors. Inflamm Bowel Dis 2013;19:1639-44.
80. Fisel P, Schaeffeler E, Schwab M. DNA methylation of ADME genes. Clin Pharmacol Ther 2016;99:512-27.
81. De Abreu R, Lambooy L, Stet E, Vogels-Mentink T, Van den Heuvel L. Thiopurine induced disturbance of DNA methylation in human
malignant cells. Adv Enzyme Regul 1995;35:251-63.
82. Lambooy LH, Leegwater PA, van den Heuvel LP, Bökkerink JP, De Abreu RA. Inhibition of DNA methylation in malignant MOLT F4
lymphoblasts by 6-mercaptopurine. Clin Chem 1998;44:556-9.
83. Hogarth LA, Redfern CP, Teodoridis JM, Hall AG, Anderson H, et al. The effect of thiopurine drugs on DNA methylation in relation to
TPMT expression. Biochem Pharmacol 2008;76:1024-35.
84. Lisanti S, Omar WA, Tomaszewski B, De Prins S, Jacobs G, et al. Comparison of methods for quantification of global DNA methylation
in human cells and tissues. PLoS One 2013;8:e79044.
85. Taki K, Fukushima T, Ise R, Horii I, Yoshida T. Microarray analysis of 6-mercaptopurine-induced-toxicity-related genes and
microRNAs in the rat placenta. J Toxicol Sci 2013;38:159-67.
86. Burgess KS, Philips S, Benson EA, Desta Z, Gaedigk A, et al. Age-Related Changes in MicroRNA Expression and Pharmacogenes in
Human Liver. Clin Pharmacol Ther 2015;98:205-15.
87. Stocco G, Martelossi S, Arrigo S, Barabino A, Aloi M, et al. Multicentric case-control study on azathioprine dose and pharmacokinetics
in early-onset pediatric inflammatory bowel disease. Inflamm Bowel Dis 2017;23:628-34.
88. Whirl-Carrillo M, McDonagh EM, Hebert JM, Gong L, Sangkuhl K, et al. Pharmacogenomics knowledge for personalized medicine.
Clin Pharmacol Ther 2012;92:414-7.
89. Kornbluth A, Sachar DB, Gastroenterology PPCotACo. Ulcerative colitis practice guidelines in adults: American college of
gastroenterology, practice parameters committee. Am J Gastroenterol 2010;105:501-23.
90. Relling MV, Evans WE. Pharmacogenomics in the clinic. Nature 2015;526:343-50.
91. Stocco G, Martelossi S, Barabino A, Fontana M, Lionetti P, Decorti G, et al. TPMT genotype and the use of thiopurines in paediatric
inflammatory bowel disease. Dig Liver Dis 2005;37:940-5.
92. von Ahsen N, Armstrong VW, Oellerich M. Rapid, long-range molecular haplotyping of thiopurine S-methyltransferase (TPMT) *3A,
*3B, and *3C. Clin Chem 2004;50:1528-34.